What's Actually Happening in the Brain During Anxiety? A Look at the Latest Research

If you've ever searched online trying to understand why anxiety happens at a biological level, you've probably run into a lot of confusing, contradictory information. A research team recently pulled together a decade's worth of studies (2014–2024) trying to map out what's going on at the molecular level in anxiety disorders. Here's what they found — and just as importantly, what the research does and doesn't prove yet.

What Kind of Study Is This?

This isn't a new experiment. It's a review, meaning the researchers searched major medical research databases for studies on the biology of anxiety, screened thousands of results, and pulled out the ones that met their criteria. They started with 3,723 studies and narrowed it down to 29 that made the final cut. Of those, 22 were done in animals (mostly mice and rats) and only 7 were done in humans. That distinction matters a lot, and we'll come back to it.

The researchers followed established, transparent methods (a pre-registered protocol and the PRISMA reporting standard used for high-quality reviews), which is a genuine strength — it means their search and selection process is traceable rather than cherry-picked.

The Big Picture: Anxiety Isn't Caused by One "Broken" Chemical

A lot of online information oversimplifies anxiety as a single chemical imbalance. This review makes clear that several systems interact — stress hormones, brain chemical messengers, genetics, and even how life experiences change the way your genes are expressed.

1. The Stress Hormone System (HPA Axis)

Your body has a built-in stress-response control center connecting the brain to your adrenal glands, which release the stress hormone cortisol. Chronic stress — especially in childhood — can leave this system stuck in overdrive, and that appears to raise the risk of anxiety later in life.

Researchers tested several compounds that seemed to calm this system down in animal studies, including lithium, a fat-derived molecule called palmitoylethanolamide, and even existing psychiatric medications repurposed for a different mechanism.

2. GABA — the Brain's Built-In "Calm Down" Signal

GABA is the brain's main inhibitory, or "brake pedal," chemical messenger. Medications like benzodiazepines work on this system, which is effective but comes with real downsides (dependency risk, tolerance). A good chunk of this research focused on finding new ways to boost GABA activity without those drawbacks — including some plant-derived compounds used in traditional medicine.

3. Serotonin — More Complicated Than "Too Little"

The popular idea of anxiety as simply "low serotonin" doesn't hold up well here. Some studies actually found anxiety linked to increased serotonin activity or disrupted serotonin transporter function — not a straightforward deficiency. In one notable study, a standard SSRI antidepressant alone didn't fully resolve anxiety-like symptoms in animals, but combining it with a plant compound (resveratrol) produced a stronger effect. This is a good illustration that anxiety involves an interplay of systems, not a single dial to turn up or down.

4. Genetics and Epigenetics — How Experience Leaves a Mark

Epigenetics refers to changes in how genes are switched on or off, without changing the DNA sequence itself — think of it like a dimmer switch rather than an on/off switch. The review highlighted studies showing that stress, trauma, and even a mother's antidepressant use during pregnancy can change these switches on genes involved in stress regulation. This is part of the biological explanation for why early-life adversity can have lasting effects on anxiety risk well into adulthood.

5. Pharmacogenomics — Medicine Tailored to Your Genes

Your genes influence how you metabolize and respond to psychiatric medications. A couple of the human studies found that specific genetic variants — in serotonin receptor genes and in liver enzymes that break down medications — predicted who responded better to a common antidepressant (sertraline) and who needed dose adjustments to avoid side effects. This growing field is part of the reason genetic testing before starting certain psychiatric medications is becoming more common in clinical practice.

Now, the Critical Appraisal: How Much Should You Trust This?

This is where it's worth slowing down, because science journalism (and even research abstracts) can make findings sound more settled than they are.

• Mostly animal research. 22 of the 29 studies were done in mice or rats, not people. Animal and human brains — especially the parts involved in anxiety — don't always translate directly, so a finding that works beautifully in a mouse doesn't guarantee it'll work in a person.

• No statistical pooling. The researchers didn't run a meta-analysis (mathematically combining results across studies) because the studies were too different from one another in design, anxiety type, and measurement. This means the review is more like a curated tour of interesting findings than a report card on "what treatment works best."

• Small, narrow human samples. The human studies that were included involved very specific groups — for example, 51 men going through alcohol withdrawal, 57 women with PTSD, or a cohort of pregnant women and their infants. Findings from groups like these don't necessarily generalize to anxiety in the broader population.

• Limited search scope. The search covered two databases and English-language studies only, so some relevant research may not have been captured.

• Most "promising" leads are early-stage. Compounds like the TSPO-targeting molecules or novel herbal extracts discussed haven't been tested in human clinical trials. They represent directions the field may go, not treatments available today.

• No industry funding or conflicts of interest were declared, which is a plus for objectivity — though it also means these findings haven't yet been backed by the kind of large, well-funded human trials needed to confirm them.

What This Actually Means for You

This research doesn't overturn today's standard, evidence-based anxiety treatments. Medications like SSRIs/SNRIs, therapy (particularly CBT), and lifestyle interventions remain the backbone of care, and that isn't changing based on this review.

What it does confirm is that anxiety is a genuine, biological condition — rooted in measurable changes in brain chemistry, stress hormone regulation, and even gene expression. It is not a character flaw, and it's not something you can simply "think your way out of."

It also points toward genuinely promising future directions, particularly around personalizing psychiatric care based on your own genetics, and around the stress hormone system and GABA pathway as targets for treatments that might work differently than what's currently available.

If you're dealing with anxiety, the most useful next step isn't chasing the newest lab finding online — it's talking with a qualified provider who can translate the current, established evidence into a treatment plan built around you.

Merkouris E, Brasinika A, Patsiavoura M, Siniosoglou C, Tsiptsios D, Triantafyllis AS, Mueller C, Mpikou I, Samara MT, Christodoulou N, et al. Molecular Basis of Anxiety: A Comprehensive Review of 2014–2024 Clinical and Preclinical Studies. International Journal of Molecular Sciences. 2025; 26(11):5417. https://doi.org/10.3390/ijms26115417

This article discusses anxiety as a biological and medical topic. If you're personally struggling with anxiety and it's affecting your daily life, it's worth reaching out to a mental health provider — you don't have to navigate it alone.